NMRA vs PSX · $283.5M cap vs P/E 17, rev $143.15B
Neumora Therapeutics, Inc. (NMRA) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
NMRA does not have a complete income-statement cache yet.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
NMRA currently screens at market cap $283.5M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the NMRA and PSX stock pages for the full models.
Not investment advice.